Breast Cancer Female, Physical Disability, Psychological Distress, Side Effects
Conditions
Keywords
Breast cancer, Hippotherapy, Global rehabilitation, Quality of life, Body image, Cognitive impairment, Fatigue, Anxiety and depression, Physical impairment, Psychological reinforcement, Social reintegration
Brief summary
Breast cancer is the most common women's cancer and the third leading cause of death. Advances in prevention, detection and primary treatment have improved overall survival leading to its growing acceptance as a long-term disease. Following the announcement of breast cancer, but also after primary treatment, some symptoms appear directly compromising psychic and physical spheres. Hippotherapy is an emerging specialized rehabilitation approach performed through specially trained horses by accredited health professionals. The proposed hippotherapy program offers key elements for physical, psychic and social reinforcement, complementing conventional care. The aim is to provide patients with tools to consolidate their self-awareness and thus strengthen their ability to cope with the disease.
Detailed description
Following the announcement and evolution of breast cancer, but also in response to primary treatment, some symptoms appear to directly compromise the psychic and/or physical sphere of the individual. Current rehabilitation programs are not sufficiently oriented to solve most of these symptoms. Hippotherapy is an emerging specialized rehabilitation approach, performed on a specially trained horse by accredited health professionals (e.g. medical doctors, physical therapists, occupational therapists, psychomotricians, speech-language pathologists, clinical psychologists). The horse is an excellent collaborator in situations of physical and psychic disability, whether temporary or consolidated. It provides human support for impairments (anatomical or physiological), activity limitations, and participation restrictions as defined by WHO. Hippotherapy has a direct action on the sensorimotor capacities of the individual but also on his cognitive abilities, i.e. attention, memory, psychomotricity, emotion, perception, sequencing of complex movements, self-experience, psychic temporality. Overall, the strong solicitation of the sensory and motor spheres promotes and interacts with the mechanisms related to the execution of tasks in the cognitive domain through the interactions of several neural networks. A randomized simple-blinded controlled trial on hippotherapy versus conventional care will be carried out. After giving their informed consent, patients will be enrolled in the trial. The 6-months program includes 1-week daily sessions of hippotherapy by the end of the initial cancer treatment followed by three short 2-days sessions with an interval of 2 months between each. The study will focus on 86 patients. Recruitment will be done over a 48-months' period. A battery of self-administered questionnaires will allow to study both the functional and psychological outcome. The primary end point will be quality of life, whereas body image, fatigue, anxiety, depression and cognitive performances will be the secondary end points.
Interventions
OTHERHippotherapy
The horse is an excellent collaborator in situations of physical and mental disability, whether temporary or consolidated. It provides support to humans towards an impairment (anatomical or physiological), a disability, or a restriction of participation as defined by the WHO in 2001. Hippotherapy has a direct action on the sensorimotor capacities of the individual but also on their cognitive capacities, such as attention, memory, psychomotricity, emotions, perceptions, the sequencing of complex movements, or the experience of oneself and the functions of time. Overall, the strong demand from the sensitive, sensory and motor spheres promotes and interacts with the mechanisms linked to the execution of tasks in the cognitive domain (memory, attention, executive functions, speed of information processing, etc.) through the interactions of several neural networks.
OTHERConventional therapy
Personalized care pathway after/during the cancer treatment takes into consideration all aspects of the disease, allowing to coordinate the intervention of the professionals that the patient might need in order to better preserve her quality of life while answering questions about cancer, prevention, treatments, or life after illness. The MIS mobilizes a chain of skills and support by providing patients: radiologists, pathologists, surgeons, oncologists, and radiation therapists, nuclear doctors, physiotherapists, cardiologists, psychologists, psychiatrists, nurses, social workers, nutritionists, dieticians, onco-geneticists, osteopaths, homeopaths, acupuncturists, sexologists, addictologists, algologists, and vascular physicians.
Sponsors
Institut Equiphoria - La Canourgue, France
Montpellier Institut du Sein - Montpellier, France
Clinique Clementville - Montpellier, France
Klésia Languedoc Service de l'Action Sociale - France
Fondation Crédit Agricole Solidarité et Développement - France
Crédit Agricole du Languedoc - France
Alliance Equiphoria
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)
Masking description
Data will be collected on the Montpellier Institut du Sein site by relying on the CRA who will follow up and check the information in due time of the self-questionnaires. The data will be duly anonymized and handled blindly. Data will be centralized on a secure server at the Equiphoria Institute. Their processing and analysis will be carried out blindly by the PI or by a private service provider (Biostatem France)
Intervention model description
A randomized simple-blind controlled trial on efficacy of the hippotherapy treatment against conventional one will be conducted. Patients selected will be randomly divided into 2 groups: hippotherapy treated group versus control group. To ensure that patients in the 2 groups are similar in all respects, except for the planned intervention, the randomization will be stratified by age representing respectively two stages: 1) Pre-menopause; 2) Post-menopause; and by type of treatment: A) Single treatment: surgery or chemotherapy or hormone therapy or radiotherapy; B) Two or more treatments.
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Confirmed histological diagnosis of breast cancer staging \[T1-T3, N0-N2 and M0\] * Patient already scheduled or ongoing treatment for surgery and/or chemotherapy and/or hormone therapy and/or radiotherapy * Having consulted a physician of the Care and Support Unit of the MIS during its health care * WHO performance index from 0 to 2 * Able to give her informed consent in writing * Able to complete questionnaires * Abduction of the hip necessary and sufficient (to allow horse riding) * Affiliated to a social security scheme * Certificate of no contraindication issued by the physician in charge
Exclusion criteria
* History of malignant tumors in the last 5 years with the exception of basocellular skin carcinoma or squamous cell carcinoma * Breast cancer as a secondary diagnosis * Medication intake or presence of conditions associated with fatigue (e.g. chronic fatigue syndrome) * Concomitant and uncontrolled severe degenerative or chronic disease * History of allergic reactions to dust and/or horsehair, or asthma * Contraindications to physical activity * History of horseback riding or hippotherapeutic treatment during the last 6 months * Clinically significant cognitive impairment or dementia * Pregnancy and breastfeeding * Majors protected by law * Patient participating in another biomedical research or in exclusion period
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Quality of life through EORTC QLQ-C30 | Before the beginning of the protocol; after the first 1-week session; at the end of the last session at 6 months | This questionnaire was designed to be cancer specific, multidimensional in structure, suitable for self-administration (brief and easy to complete), and applicable in a wide range of cultural contexts. The scores ranges from 0 to 100, a higher score represents a higher (better) level of functioning. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in Body image representation through Body Image Scale (BIS) | Before the beginning of the protocol; after the first 1-week session; at the end of the last session at 6 months | The questionnaire focuses on patients' emotional and behavioral experiences of their body image, resulting from cancer and treatment, including aspects of perceived physical appearance, body integrity, and seduction capacity. The total score ranges from 0 to 30. A higher score means a higher level of body image disturbance. |
| Changes in Fatigue sensation through Multidimensional Fatigue Inventory (MFI-20) | Before the beginning of the protocol; after the first 1-week session; at the end of the last session at 6 months | MFI seems to be one of the best questionnaires to provide a fatigue profile. Its psychometric properties have been studied in different populations and it is easy to administer. Score ranges from 0 to 100. Higher total scores correspond with more acute levels of fatigue. |
| Changes in anxiety and depression through Hospital Anxiety and Depression Scale (HADS) | Before the beginning of the protocol; after the first 1-week session; at the end of the last session at 6 months | This scale was constructed excluding any item concerning somatic aspects, aspects that could be confused between physical and mental illness. It is a self-questionnaire to be completed according to oneself condition during the past week. Score ranges from 0 to 21 for each item. Higher total scores correspond to presence of the respective state. |
| Changes in the Cognitive sphere assessment through Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) | Before the beginning of the protocol; after the first 1-week session; at the end of the last session at 6 months | The questions are grouped into six cognitive domains (memory, verbal fluency, concentration, mental sharpness, resistance to interference, multitasking ability) and two sub-criteria (visibility of the disorder by the entourage, impact on the quality of life). 37-item ranging from 0 to 4 consist of four subscales. Higher scores represent better functioning. |
Countries
France
Outcome results
None listed